Researcher index

Authors in the psilocybin and psilocin literature

Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.

Davis AK

27 indexed publications match this author name.

ORCID: Not found in stored metadata
OpenAlex: Not found in stored metadata

Author watchlist

Create a confirmed email alert for new publications matching this author.

Topics

Depression 13 Safety 11 Observational Study 11 Mystical Experience 10 Review Article 7 Clinical Trial 7 Spirituality 5 Adverse Events 5 Anxiety 5 Wellbeing 4 Meta-Analysis 4 Addiction 4

Journals

Journal of psychoactive drugs 3 Journal of psychopharmacology (Oxford, England) 3 PsyArXiv 2 PloS one 2 JAMA psychiatry 2 Expert review of clinical pharmacology 1 Psychedelic medicine (New Rochelle, N.Y.) 1 Therapeutic advances in psychopharmacology 1

Publication history

From molecules to meaning: unpacking the antidepressant mechanisms of psychedelic drugs.Expert review of clinical pharmacology · 2025-05-01 A Field-Wide Review and Analysis of Study Materials Used in Psilocybin Trials: Assessment of Two Decades of Research.Psychedelic medicine (New Rochelle, N.Y.) · 2025-03-01 Effect of psilocybin therapy on suicidal ideation, attempts, and deaths in people with psychiatric diagnoses: a systematic review and meta-analysis.Therapeutic advances in psychopharmacology · 2025-01-01 Preliminary safety and effectiveness of psilocybin-assisted therapy in adults with fibromyalgia: An open-label, pilot clinical trialPsyArXiv · 2024-11-04 Psychedelic research at a crossroads.Science (New York, N.Y.) · 2024-09-20 The therapeutic alliance between study participants and intervention facilitators is associated with acute effects and clinical outcomes in a psilocybin-assisted therapy trial for major depressive disorder.PloS one · 2024-01-01 Translation and Initial Psychometric Evaluation of Spanish Versions of Three Psychedelic Acute Effects Measures: Mystical, Challenging, and Insight Experiences.Journal of psychoactive drugs · 2024-01-01 Assessing the risk of symptom worsening in psilocybin-assisted therapy for depression: A systematic review and individual participant data meta-analysis.Psychiatry research · 2023-09-01 Study protocol of an open-label proof-of-concept trial examining the safety and clinical efficacy of psilocybin-assisted therapy for veterans with PTSD.BMJ open · 2023-05-04 Knowledge, Perceptions, and Use of Psychedelics among Individuals with Fibromyalgia.Journal of psychoactive drugs · 2023-01-01 Inconsistencies between national drug policy and professional beliefs about psychoactive drugs among psychiatrists in the United States.The International journal on drug policy · 2022-10-01 Psilocybin use patterns and perception of risk among a cohort of Black individuals with Opioid Use Disorder.Journal of psychedelic studies · 2022-09-01 Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: Prospective 12-month follow-up.Journal of psychopharmacology (Oxford, England) · 2022-02-01 Psilocybin for the Treatment of Depression: A Promising New Pharmacotherapy Approach.Current topics in behavioral neurosciences · 2022-01-01 Race, Ethnic, and Sex Differences in Prevalence of and Trends in Hallucinogen Consumption Among Lifetime Users in the United States Between 2015 and 2019.Frontiers in epidemiology · 2022-01-01 Attitudes and Beliefs about the Therapeutic Use of Psychedelic Drugs among Psychologists in the United States.Journal of psychoactive drugs · 2022-01-01 Psilocybin therapy increases cognitive and neural flexibility in patients with major depressive disorder.Translational psychiatry · 2021-11-08 Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder: A Randomized Clinical Trial.JAMA psychiatry · 2021-05-01 Errors in a Response Rate and in Effect Sizes in Study of Psilocybin-Assisted Therapy for Major Depressive Disorder.JAMA psychiatry · 2021-05-01 Development of the Psychological Insight Questionnaire among a sample of people who have consumed psilocybin or LSD.Journal of psychopharmacology (Oxford, England) · 2021-04-01 People of color in North America report improvements in racial trauma and mental health symptoms following psychedelic experiences.Drugs (Abingdon, England) · 2021-01-01 A Meta-Analysis of Placebo-Controlled Trials of Psychedelic-Assisted TherapyPsyArXiv · 2020-10-28 Long-term effects of psychedelic drugs: A systematic review.Neuroscience and biobehavioral reviews · 2020-06-01 Cessation and reduction in alcohol consumption and misuse after psychedelic use.Journal of psychopharmacology (Oxford, England) · 2019-09-01 Survey of subjective "God encounter experiences": Comparisons among naturally occurring experiences and those occasioned by the classic psychedelics psilocybin, LSD, ayahuasca, or DMT.PloS one · 2019-01-01 Persisting Reductions in Cannabis, Opioid, and Stimulant Misuse After Naturalistic Psychedelic Use: An Online Survey.Frontiers in psychiatry · 2019-01-01 Intensity of Mystical Experiences Occasioned by 5-MeO-DMT and Comparison With a Prior Psilocybin Study.Frontiers in psychology · 2018-01-01

Author directory